在Rgs5缺乏的瘤中,血管正常化促进了免疫破坏
Juliana Hamzah1, Manfred Jugold, Fabian Kiessling
1Western Australian Institute for Medical Research, UWA Centre for Medical Research, Perth, Western Australia 6000, Australia.
Nature
|April 18, 2008
概括
调节G蛋白信号5 (Rgs5) 调节异常的瘤血管形状. 在小鼠中,Rgs5的损失使瘤血管正常化,改善免疫细胞透,并延长生存时间.
科学领域:
- 在瘤学瘤学.
- 血管生物学 血管生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 瘤血管系异常,阻碍免疫细胞透,限制免疫疗法的有效性.
- 异常瘤血管生成的分子驱动因素在很大程度上是未知的.
- 瘤血管生成支持瘤生长,是有效治疗癌症的重要障碍.
研究的目的:
- 确定调节异常瘤血管形态的关键基因.
- 调查G蛋白信号传递5 (Rgs5) 调节器在瘤血管生成中的作用.
- 确定Rgs5损失对瘤血管正常化和免疫反应的影响.
主要方法:
- 利用小鼠模型研究瘤血管形态和血管生成.
- 研究了Rgs5在调节瘤血管发育中的功能.
- 评估了Rgs5损失对瘤缺氧,血管泄漏和免疫细胞透的影响.
主要成果:
- 在小鼠中确定Rgs5作为异常瘤血管形态的主调节者.
- 丢失Rgs5导致细胞周细胞成熟和血管正常化.
- 缺少Rgs5可以减少瘤缺氧和血管泄漏,增强免疫效应细胞的流入并延长小鼠的存活时间.
结论:
- Rgs5在建立异常的瘤血管系统中起着至关重要的作用.
- 向Rgs5可以使瘤血管生成正常化,改善抗瘤免疫力和治疗结果.
- 这项研究揭示了G蛋白信号传递在瘤血管生成和免疫治疗中的新作用.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

